These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 15930013

  • 1. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance.
    Dyment DA, Herrera BM, Cader MZ, Willer CJ, Lincoln MR, Sadovnick AD, Risch N, Ebers GC.
    Hum Mol Genet; 2005 Jul 15; 14(14):2019-26. PubMed ID: 15930013
    [Abstract] [Full Text] [Related]

  • 2. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.
    Chao MJ, Barnardo MC, Lui GZ, Lincoln MR, Ramagopalan SV, Herrera BM, Dyment DA, Sadovnick AD, Ebers GC.
    Hum Mol Genet; 2007 Aug 15; 16(16):1951-8. PubMed ID: 17584771
    [Abstract] [Full Text] [Related]

  • 3. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex.
    Chao MJ, Ramagopalan SV, Herrera BM, Lincoln MR, Dyment DA, Sadovnick AD, Ebers GC.
    Hum Mol Genet; 2009 Jan 15; 18(2):261-6. PubMed ID: 19098025
    [Abstract] [Full Text] [Related]

  • 4. Parent-of-origin effects at the major histocompatibility complex in multiple sclerosis.
    Chao MJ, Herrera BM, Ramagopalan SV, Deluca G, Handunetthi L, Orton SM, Lincoln MR, Sadovnick AD, Ebers GC.
    Hum Mol Genet; 2010 Sep 15; 19(18):3679-89. PubMed ID: 20634196
    [Abstract] [Full Text] [Related]

  • 5. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R, Uxa L, Bratina A, Bosco A, Srinivasaraghavan B, Minagar A, Ukmar M, Benedetto Sy, Zorzon M.
    Int Rev Neurobiol; 2007 Sep 15; 79():521-35. PubMed ID: 17531857
    [Abstract] [Full Text] [Related]

  • 6. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
    Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, Briggs F, Cree BC, Begovich AB, Villoslada P, Montalban X, Uccelli A, Savettieri G, Lincoln RR, DeLoa C, Haines JL, Pericak-Vance MA, Compston A, Hauser SL, Oksenberg JR.
    Hum Mol Genet; 2006 Sep 15; 15(18):2813-24. PubMed ID: 16905561
    [Abstract] [Full Text] [Related]

  • 7. Maternal - offspring HLA-DRB1 compatibility in multiple sclerosis.
    Willer CJ, Dyment DA, Sadovnick AD, Ebers GC.
    Tissue Antigens; 2005 Jul 15; 66(1):44-7. PubMed ID: 15982256
    [Abstract] [Full Text] [Related]

  • 8. HLA and susceptibility to juvenile idiopathic arthritis: a study of affected sibpairs in an isolated Finnish population.
    Säilä H, Pitkäniemi J, Tuomilehto J, Savolainen A, Alakulppi N, Tuomilehto-Wolf E, Leirisalo-Repo M, Aho K.
    J Rheumatol; 2004 Nov 15; 31(11):2281-5. PubMed ID: 15517645
    [Abstract] [Full Text] [Related]

  • 9. HLA-patterns in patients with multiple sclerosis and type I diabetes mellitus: evidence for possible mutual exclusion of both diseases.
    Lobnig BM, Chantelau E, Vidgrén G, Van Landeghem AA, Kinnunen L, Tuomilehto-Wolf E.
    Diabetes Metab; 2002 Jun 15; 28(3):217-21. PubMed ID: 12149602
    [Abstract] [Full Text] [Related]

  • 10. Parent-of-origin of HLA-DRB1*1501 and age of onset of multiple sclerosis.
    Ramagopalan SV, Byrnes JK, Dyment DA, Guimond C, Handunnetthi L, Disanto G, Yee IM, Ebers GC, Sadovnick AD.
    J Hum Genet; 2009 Sep 15; 54(9):547-9. PubMed ID: 19629136
    [Abstract] [Full Text] [Related]

  • 11. HLA class II DR and DQ genotypes and haplotypes associated with rheumatic fever among a clinically homogeneous patient population of Latvian children.
    Stanevicha V, Eglite J, Zavadska D, Sochnevs A, Shantere R, Gardovska D.
    Arthritis Res Ther; 2007 Sep 15; 9(3):R58. PubMed ID: 17559688
    [Abstract] [Full Text] [Related]

  • 12. Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility.
    Fernandez-Morera JL, Rodriguez-Rodero S, Tunon A, Martinez-Borra J, Vidal-Castineira JR, Lopez-Vazquez A, Rodrigo L, Rodrigo P, González S, Lahoz CH, Lopez-Larrea C.
    Tissue Antigens; 2008 Jul 15; 72(1):54-9. PubMed ID: 18588574
    [Abstract] [Full Text] [Related]

  • 13. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.
    Stankovich J, Butzkueven H, Marriott M, Chapman C, Tubridy N, Tait BD, Varney MD, Taylor BV, Foote SJ, ANZgene Consortium, Kilpatrick TJ, Rubio JP.
    Tissue Antigens; 2009 Jul 15; 74(1):17-21. PubMed ID: 19392788
    [Abstract] [Full Text] [Related]

  • 14. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.
    Wu JS, James I, Wei Qiu, Castley A, Christiansen FT, Carroll WM, Mastaglia FL, Kermode AG.
    Mult Scler; 2010 May 15; 16(5):526-32. PubMed ID: 20207784
    [Abstract] [Full Text] [Related]

  • 15. HLA-DRB1 and multiple sclerosis in Malta.
    Dean G, Yeo TW, Goris A, Taylor CJ, Goodman RS, Elian M, Galea-Debono A, Aquilina A, Felice A, Vella M, Sawcer S, Compston DA.
    Neurology; 2008 Jan 08; 70(2):101-5. PubMed ID: 18057318
    [Abstract] [Full Text] [Related]

  • 16. HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility.
    Chao MJ, Barnardo MC, Lincoln MR, Ramagopalan SV, Herrera BM, Dyment DA, Montpetit A, Sadovnick AD, Knight JC, Ebers GC.
    Proc Natl Acad Sci U S A; 2008 Sep 02; 105(35):13069-74. PubMed ID: 18765817
    [Abstract] [Full Text] [Related]

  • 17. The HLA locus and multiple sclerosis in Sicily.
    Brassat D, Salemi G, Barcellos LF, McNeill G, Proia P, Hauser SL, Oksenberg JR, Savettieri G.
    Neurology; 2005 Jan 25; 64(2):361-3. PubMed ID: 15668443
    [Abstract] [Full Text] [Related]

  • 18. Genetic contribution of major histocompatibility complex class II region to type 1 autoimmune hepatitis susceptibility in Venezuela.
    Fortes Mdel P, Machado IV, Gil G, Fernández-Mestre M, Dagher L, León RV, Bianco NE, Tassinari P.
    Liver Int; 2007 Dec 25; 27(10):1409-16. PubMed ID: 17927716
    [Abstract] [Full Text] [Related]

  • 19. HLA-DRB1 and month of birth in multiple sclerosis.
    Ramagopalan SV, Link J, Byrnes JK, Dyment DA, Giovannoni G, Hintzen RQ, Sundqvist E, Kockum I, Smestad C, Lie BA, Harbo HF, Padyukov L, Alfredsson L, Olsson T, Sadovnick AD, Hillert J, Ebers GC.
    Neurology; 2009 Dec 15; 73(24):2107-11. PubMed ID: 20018638
    [Abstract] [Full Text] [Related]

  • 20. No evidence for an effect of DNA methylation on multiple sclerosis severity at HLA-DRB1*15 or HLA-DRB5.
    Handel AE, De Luca GC, Morahan J, Handunnetthi L, Sadovnick AD, Ebers GC, Ramagopalan SV.
    J Neuroimmunol; 2010 Jun 15; 223(1-2):120-3. PubMed ID: 20394989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.